Oxidative Stress Assay Market Strategies: Enhancing Methodologies for Better Results

 The global oxidative stress assay market size is anticipated to reach USD 2.09 billion by 2030 and is projected to grow at a CAGR of 9.43% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of oxidative stress-associated diseases such as cardiovascular diseases, respiratory diseases, diabetes, and others and research & development activities related to these diseases are major factors contributing to the market growth. For instance, according to the U.S. Department of Health and Human Services, in 2021, the global prevalence of diabetes among 20- to 79-year-old people was estimated at around 536.6 million, and it is expected to reach 783.2 million by 2045.

Cancer is one of the lucrative segments of the oxidative stress assay (OSA) market. Cellular damage induced by oxidative stress may activate cancer genes and inactivate tumor suppressor genes, leading to cancer development. Moreover, an increase in the cancer patient base is further expected to increase the market uptake of OSA in the coming years. According to the NCBI estimates, there will be around 30 million cancer cases by 2040, a rise of 57% compared to 2020 which is expected to create more opportunities for OSA market.

Academic and research institutes are involved in research activities to study oxidative stress in different health issues and develop novel solutions for diagnosing and treating these diseases. For instance, in August 2023, researchers at the Medical University of Lodz conducted a study to evaluate the oxidative stress in obstructive sleep apnea. The level of inflammatory biomarkers such as interleukins and tumor necrosis factor have been higher in obstructive sleep apnea patients.

Gather more insights about the market drivers, restrains and growth of the Global Oxidative Stress Assay Market

Investigating oxidative stress and glutathione levels related to infectious diseases is further expected to create novel market opportunities for the key players. For instance, in August 2023, a report published by bioRxiv stated that the reactive oxygen species (ROS) increase antibiotic resistance in E. coli when exposed to sublethal levels of bactericidal antibiotics. Moreover, in December 2021, researchers at Baylor College of Medicine found increased oxidative stress and glutathione deficiency among COVID-19 patients.

 

Oxidative Stress Assay Market Report Highlights

  • Based on product, the consumables segment led the market with the largest revenue share of 44.63% in 2023, owing to increasing adoption of OSA in different end-use applications
  • Based on test type, the reactive oxygen species-based assays segment is expected to grow at the fastest CAGR over the forecast period
  • Based on technology, the ELISA technology segment held the market with the largest market share of 36.09% in 2023, owing to high market penetration and accurate results
  • Based on disease type, the cancer segment is projected to grow at the fastest CAGR during the forecast period, due to an increasing patient base coupled high mortality rate and increasing R&D activities
  • Based on end-user, the pharmaceutical & biotechnology industries dominated the global oxidative stress assay due to the significant involvement of companies in research activities to develop novel therapeutics for targeted diseases
  • North America dominated the market with the largest revenue share in 2023, owing to factors such as high R&D expenditure, presence of major pharmaceutical companies, and government support for quality healthcare

 

Oxidative Stress Assay Market Segmentation

Grand View Research has segmented the global oxidative stress assay market on the basis of product, test type, technology, disease type, end user, and region:

Oxidative Stress Assay Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Instruments
  • Consumables
    • Kits
    • Reagents
  • Services

Oxidative Stress Assay Test Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Indirect Assays
    • Protein-Based Assays
    • Lipid-Based Assays
    • Nucleic Acid-Based Assays
  • Antioxidant Capacity Assays
    • Glutathione Assays
    • Ascorbic Acid Assays
    • Cell-Based Exogenous Antioxidant Assays
  • Enzyme-Based Assays
  • Reactive Oxygen Species-Based Assays

Oxidative Stress Assay Technology Outlook (Revenue, USD Million, 2018 - 2030)

  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Flow Cytometry
  • Chromatography
  • Microscopy
  • Others

Oxidative Stress Assay Disease Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Cardiovascular disease
  • Respiratory Diseases
  • Cancer
  • Diabetes
  • Others

Oxidative Stress Assay End-user Outlook (Revenue, USD Million, 2018 - 2030)

  • Pharmaceutical and Biotechnology Industries
  • Academic Research institutes
  • Contract Research Organizations
  • Clinical Laboratories
  • Others

Oxidative Stress Assay Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • UK
    • Spain
    • France
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

List of Key Players in the Oxidative Stress Assay Market

  • Abcam Limited
  • AMSBIO
  • Cell Biolabs, Inc.
  • Enzo Life Sciences, Inc.
  • Merck KGaA
  • ImmunoChemistry Technologies
  • Promega Corporation
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • OXFORD BIOMEDICAL RESEARCH

 Order a free sample PDF of the Oxidative Stress Assay Market Intelligence Study, published by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more